Intake of polyunsaturated fat in relation to mortality among statin users and non-users in the Southern Community Cohort Study

Published on Nov 1, 2015in Nutrition Metabolism and Cardiovascular Diseases3.34
· DOI :10.1016/j.numecd.2015.07.006
J. N. Kiage1
Estimated H-index: 1
(VUMC: Vanderbilt University Medical Center),
Uchechukwu Sampson33
Estimated H-index: 33
+ 8 AuthorsEdmond K. Kabagambe39
Estimated H-index: 39
(VUMC: Vanderbilt University Medical Center)
Abstract Background and aims Consumption of polyunsaturated fatty acids (PUFA), especially the n3-series, may protect against cardiovascular disease (CVD), but recent randomized studies have failed to demonstrate these benefits. One of the prevailing hypotheses is that PUFA intake may not confer benefits beyond those provided by statins, but studies comparing statin users to non-users with regard to effects of PUFA are lacking. Methods and results Black and white men and women (n = 69,559) in the Southern Community Cohort Study were studied. Cox regression models adjusting for age, sex, race, BMI, recruitment site, education, income, smoking, diabetes, and dietary variables were used. Results At baseline the mean ± SD age was 52 ± 9 years, 60% of participants were women, 54% had hypertension and 16% used statins. We observed modest inverse associations between n3-PUFA and n6-PUFA intake with mortality among non-statin users but not among statin users. In adjusted analyses, the HRs (95% CIs) for all-cause mortality (6,396 deaths over a median of 6.4 years) comparing the highest to the lowest quintile were 0.90 (0.82–1.00) for n3-PUFA and 0.80 (0.70–0.92) for n6-PUFA among non-statin users, whereas they were 1.06 (0.87–1.28) and 0.96 (0.78–1.19) for n3-PUFA and n6-PUFA, respectively, among statin users. Conclusions Our results suggest potential benefits of PUFA consumption on mortality which are only apparent in the absence of statin therapy. It seems prudent to consider the potential benefit of PUFA consumption in the primary prevention of CVD among patients who are not candidates for statin therapy but are at increased risk for CVD and mortality.
Figures & Tables
  • References (44)
  • Citations (8)
📖 Papers frequently viewed together
3 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
#2Jordan FulcherH-Index: 5
#3Rachel O'ConnellH-Index: 19
Last. Anthony C. Keech (USYD: University of Sydney)H-Index: 62
view all 19 authors...
UK Medical Research Council, British Heart Foundation, Australian National Health and Medical Research Council, European Community Biomed Program.
438 CitationsSource
Background: Whether elevated intakes of trans fatty acids (TFAs) increase the risk of stroke remains unclear. Except for the Women's Health Initiative–Observational Study, most studies that directly assessed the association between TFA intake and stroke yielded null results. Objective: The aim of this study was to investigate the association between TFA intake and stroke incidence. Design: We prospectively investigated the association between TFA intake and stroke incidence in black and white me...
26 CitationsSource
Background—Lifestyle and socioeconomic status have been implicated in the prevalence of hypertension; thus, we evaluated factors associated with hypertension in a cohort of blacks and whites with similar socioeconomic status characteristics. Methods and Results—We evaluated the prevalence and factors associated with self-reported hypertension (SR-HTN) and ascertained hypertension (A-HTN) among 69 211 participants in the Southern Community Cohort Study. Multivariable logistic regression models we...
36 CitationsSource
#1Loren LipworthH-Index: 40
#2Sergio FazioH-Index: 65
Last. Uchechukwu SampsonH-Index: 33
view all 9 authors...
Purpose The primary objective of this study is to examine the race-specific associations between statin use and overall mortality, as well as cardiovascular and cancer mortality, among blacks and whites in the Southeastern United States (US). Little is known about these associations in blacks.
13 CitationsSource
#1Katherine M. Livingstone (University of Reading)H-Index: 17
#2D.I. Givens (University of Reading)H-Index: 32
Last. Julie A. Lovegrove (University of Reading)H-Index: 43
view all 5 authors...
Background and aims: Arterial stiffness is an independent predictor of cardiovas- cular disease (CVD) events and all-cause mortality and may be differentially affected by die- tary fatty acid (FA) intake. The aim of this study was to investigate the relationship between FA consumption and arterial stiffness and blood pressure in a community-based population. Methods and results: The Caerphilly Prospective Study recruited 2398 men, aged 45e59 years, who were followed up at 5-year intervals for a ...
25 CitationsSource
#1M. C. RoncaglioniH-Index: 1
#2M. TombesiH-Index: 1
Last. C. ZulianiH-Index: 1
view all 1000 authors...
BACKGROUND: Trials have shown a beneficial effect of n-3 polyunsaturated fatty acids in patients with a previous myocardial infarction or heart failure. We evaluated the potential benefit of such therapy in patients with multiple cardiovascular risk factors or atherosclerotic vascular disease who had not had a myocardial infarction. METHODS: In this double-blind, placebo-controlled clinical trial, we enrolled a cohort of patients who were followed by a network of 860 general practitioners in Ita...
291 CitationsSource
Background: A high intake of trans fatty acids decreases HDL cholesterol and is associated with increased LDL cholesterol, inflammation, diabetes, cancer, and mortality from cardiovascular disease. The relation between trans fat intake and all-cause mortality has not been established. Objective: The aim of this study was to determine the relation between trans fat intake and all-cause mortality. Design: We used data from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study...
32 CitationsSource
#1Michel de Lorgeril (UJF: Joseph Fourier University)H-Index: 19
#2Patricia Salen (UJF: Joseph Fourier University)H-Index: 24
Last. Mikael RabaeusH-Index: 5
view all 4 authors...
Early randomized controlled trials (RCTs) demonstrated the health benefits of omega-3 fatty acids (n-3), whereas recent RCTs were negative. We now address the issue, focusing on the temporal changes having occurred: most patients in recent RCTs are no longer n-3 deficient and the vast majority are now treated with statins. Recent RCTs testing n-3 against arrhythmias suggest that n-3 reduce the risk only in patients not taking a statin. Other recent RCTs in secondary prevention were negative alth...
38 CitationsSource
#1Loren Lipworth (VUMC: Vanderbilt University Medical Center)H-Index: 40
#2Henry Okafor (Meharry Medical College)H-Index: 5
Last. Dawood Darbar (VUMC: Vanderbilt University Medical Center)H-Index: 41
view all 7 authors...
Despite a greater burden of traditional risk factors, atrial fibrillation (AF) is less common among blacks than whites for reasons that are unclear. The aim of this study was to examine race- and gender-specific influences of demographic, lifestyle, anthropometric, and medical factors on AF in a large cohort of blacks and whites. Among white and black participants in the Southern Community Cohort Study (SCCS) aged ≥65 years receiving Medicare coverage from 1999 to 2008 (n = 8,836), diagnoses of ...
31 CitationsSource
#1Luis I. Juncos (CONICET: National Scientific and Technical Research Council)H-Index: 3
#2Luis A. Juncos (UMMC: University of Mississippi Medical Center)H-Index: 17
Last. Néstor H. García (CONICET: National Scientific and Technical Research Council)H-Index: 6
view all 3 authors...
7 CitationsSource
Cited By8
#1Julia K. BirdH-Index: 6
#2Philip C. CalderH-Index: 105
Last. Manfred EggersdorferH-Index: 19
view all 3 authors...
Decreases in global cardiovascular disease (CVD) mortality and morbidity in recent decades can be partly attributed to cholesterol reduction through statin use. n-3 long chain polyunsaturated fatty acids are recommended by some authorities for primary and secondary CVD prevention, and for triglyceride reduction. The residual risk of CVD that remains after statin therapy may potentially be reduced by n-3 long chain polyunsaturated fatty acids. However, the effects of concomitant use of statins an...
8 CitationsSource
#1Ryan S. Hsi (VUMC: Vanderbilt University Medical Center)H-Index: 18
#2Edmond K. Kabagambe (VUMC: Vanderbilt University Medical Center)H-Index: 39
Last. Loren Lipworth (VUMC: Vanderbilt University Medical Center)H-Index: 40
view all 6 authors...
Objective To investigate race-sex associations with risk among whites and blacks in the southeastern United States. The relationship between race, sex, and kidney stone risk is poorly understood. Methods Participants were 42,136 black and white adults enrolled in the Southern Community Cohort Study between 2002 and 2009, with no history of kidney stones and receiving Medicare or Medicaid services. Incident kidney stone diagnoses through December 2014 were determined via linkage with Centers for ...
1 CitationsSource
Docosahexaenoic acid (DHA) is present in high concentrations in salmon, herring, and trout. Epidemiologic studies have shown that high dietary consumption of these and other oily fish is associated with reduced rates of myocardial infarction, atherosclerosis, and other ischemic pathologies. Atherosclerosis is induced by inflammation and can lead to acute cardiovascular events and extensive plaque. DHA inhibits the development of inflammation in endothelial cells, alters the function and regulati...
12 CitationsSource
#1Steven Hamley (Deakin University)H-Index: 6
A cornerstone of conventional dietary advice is the recommendation to replace saturated fatty acids (SFA) with mostly n-6 polyunsaturated fatty acids (PUFA) to reduce the risk of coronary heart disease (CHD). Many clinical trials aimed to test this advice and have had their results pooled in several meta-analyses. However, earlier meta-analyses did not sufficiently account for major confounding variables that were present in some of those trials. Therefore, the aim of the study was to account fo...
28 CitationsSource
#1Rakesh Malhotra (UCSD: University of California, San Diego)H-Index: 26
#2Kerri L. Cavanaugh (Vandy: Vanderbilt University)H-Index: 26
Last. Edmond K. Kabagambe (Vandy: Vanderbilt University)H-Index: 39
view all 6 authors...
Background Whether polyunsaturated fatty acids (PUFA) are associated with end-stage renal disease (ESRD) in populations with a high burden of risk factors for kidney disease is unknown. We sought to determine whether PUFA intake is associated with ESRD.
5 CitationsSource
view all 7 authors...
#1James N KiageH-Index: 4
#2Uchechukwu Sampson (NIH: National Institutes of Health)H-Index: 33
Last. Edmond K. KabagambeH-Index: 39
view all 11 authors...
1 CitationsSource